Latest Regulatory News

Page 31 of 937
Australis Oil and Gas has submitted a permit application for the first well under its US$46.25 million carried work program in the Tuscaloosa Marine Shale, targeting a Q4 2026 spud and expanding its held-by-production acreage.
Maxwell Dee
Maxwell Dee
2 July 2026
Wide Open Agriculture is closing its German plant and pivoting to contract manufacturing in Asia to cut costs and scale lupin ingredient production efficiently under new CEO Craig Swan.
Ada Torres
Ada Torres
2 July 2026
Telix Pharmaceuticals has gained FDA alignment to advance Part 2 of its ProstACT Global Phase 3 trial for TLX591-Tx in metastatic castration-resistant prostate cancer, setting the stage for U.S. enrolment pending regulatory approval.
Ada Torres
Ada Torres
2 July 2026
BCAL Diagnostics has acquired a 10.2% stake in Genetic Signatures for $1.39 million, aiming to merge early cancer detection with infectious disease diagnostics and expand its international footprint.
Ada Torres
Ada Torres
2 July 2026
Lakes Blue Energy is positioning its Wombat Gas Project as a key contributor to Victoria's energy security and emerging AI infrastructure, with a conceptual study projecting a post-tax NPV10 of A$605 million and first gas in early 2029.
Maxwell Dee
Maxwell Dee
2 July 2026
Algorae Pharmaceuticals has been appointed as a supplier under a NSW Health public hospital supply contract, marking a strategic milestone despite uncertain immediate revenue impact.
Ada Torres
Ada Torres
2 July 2026
Island Pharmaceuticals has strengthened its intellectual property portfolio with a Singapore patent covering ISLA-101 for flavivirus infections, including Dengue and Chikungunya, extending commercial exclusivity to 2034 in a key Asia-Pacific market.
Victor Sage
Victor Sage
2 July 2026
Scalare Partners has locked in a $5 million convertible note facility from Blackstone Mercantile, paving the way for up to $25 million in funding subject to shareholder approval. The deal includes a 60:1 share consolidation and a bonus option issue designed to soften dilution for existing shareholders.
Sophie Babbage
Sophie Babbage
2 July 2026
Neurotech International has received Notices of Allowance from the USPTO for two patents covering its lead drug NTI164, reinforcing its intellectual property position as it advances Phase 3 trials for autism spectrum disorder.
Ada Torres
Ada Torres
2 July 2026
Peter Warren Automotive’s planned acquisition of Wakeling Automotive hits a regulatory and timing impasse as vendors refuse to extend the deal’s Sunset Date despite ACCC application adjustments.
Victor Sage
Victor Sage
2 July 2026
Prodigy Gold is progressing key regulatory approvals to restart mining at its Old Pirate gold mine, supported by encouraging ore sorting testwork that significantly upgrades gold grades and promises operational efficiencies.
Maxwell Dee
Maxwell Dee
2 July 2026
Golden Horse Minerals has delivered a fresh wave of strong gold intercepts from its Hopes Hill project, reinforcing the prospect of a regionally significant deposit with a maiden resource estimate slated for later this year.
Maxwell Dee
Maxwell Dee
2 July 2026